Michael Mahoney - Boston Scientific Pres Chairman
| B1SX34 Stock | BRL 554.58 11.78 2.17% |
Insider
Michael Mahoney is Pres Chairman of Boston Scientific
| Age | 58 |
| Phone | 508 683 4000 |
| Web | https://www.bostonscientific.com |
Boston Scientific Management Efficiency
The company has return on total asset (ROA) of 0.0425 % which means that it generated a profit of $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0407 %, meaning that it generated $0.0407 on every $100 dollars invested by stockholders. Boston Scientific's management efficiency ratios could be used to measure how well Boston Scientific manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Rashmi Vasisht | Cognizant Technology Solutions | N/A | |
| John Kim | Cognizant Technology Solutions | 55 | |
| Clive Downie | Unity Software | 50 | |
| Anirma Gupta | Unity Software | N/A | |
| Vamsi Pudipeddi | Align Technology | 51 | |
| Stuart Hockridge | Align Technology | 51 | |
| John Morici | Align Technology | 56 | |
| CFA Davis | Unity Software | N/A | |
| Christine Pambianchi | Verizon Communications | 50 | |
| Julie Coletti | Align Technology | 54 | |
| Vittorio Colao | Verizon Communications | 57 | |
| Lawrence Wieser | Cognizant Technology Solutions | N/A | |
| Jan Siegmund | Cognizant Technology Solutions | 59 | |
| Marc Whitten | Unity Software | 52 | |
| Samantha Hammock | Verizon Communications | 44 | |
| David Helgason | Unity Software | 45 | |
| Tamara Erwin | Verizon Communications | 58 | |
| Joachim Ante | Unity Software | 41 | |
| Zelko Relic | Align Technology | 58 | |
| Nicholas Francis | Unity Software | N/A | |
| Shirley Stacy | Align Technology | N/A | |
Management Performance
| Return On Equity | 0.0407 | |||
| Return On Asset | 0.0425 |
Boston Scientific Leadership Team
Elected by the shareholders, the Boston Scientific's board of directors comprises two types of representatives: Boston Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Boston. The board's role is to monitor Boston Scientific's management team and ensure that shareholders' interests are well served. Boston Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Boston Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jodi Eddy, VP Officer | ||
| Vance Brown, Gen VP | ||
| Catherine Jennings, VP Interventions | ||
| Joseph Fitzgerald, Ex Cardiology | ||
| John Sorenson, Ex Operations | ||
| Daniel Brennan, Ex CFO | ||
| Jeffrey Mirviss, Ex Interventions | ||
| Michael Mahoney, Pres Chairman | ||
| Jonathan Monson, Global VP | ||
| Susan Lisa, VP Relations |
Boston Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Boston Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0407 | |||
| Return On Asset | 0.0425 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 405.56 B | |||
| Shares Outstanding | 1.43 B | |||
| Price To Earning | 53.01 X | |||
| Price To Book | 3.82 X | |||
| Price To Sales | 28.55 X | |||
| Revenue | 11.89 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Boston Stock
Boston Scientific financial ratios help investors to determine whether Boston Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boston with respect to the benefits of owning Boston Scientific security.